Binfeng Lu

12.1k total citations · 2 hit papers
141 papers, 9.7k citations indexed

About

Binfeng Lu is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Binfeng Lu has authored 141 papers receiving a total of 9.7k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Immunology, 67 papers in Oncology and 33 papers in Molecular Biology. Recurrent topics in Binfeng Lu's work include Immune Cell Function and Interaction (53 papers), Cancer Immunotherapy and Biomarkers (37 papers) and Immunotherapy and Immune Responses (28 papers). Binfeng Lu is often cited by papers focused on Immune Cell Function and Interaction (53 papers), Cancer Immunotherapy and Biomarkers (37 papers) and Immunotherapy and Immune Responses (28 papers). Binfeng Lu collaborates with scholars based in United States, China and Germany. Binfeng Lu's co-authors include Richard A. Flavell, Jingting Jiang, Yibei Zhu, Xueguang Zhang, Changping Wu, Guangbo Zhang, Lujun Chen, Xueguang Zhang, Min Yang and Robert L. Ferris and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Binfeng Lu

138 papers receiving 9.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neuronal Activity–Induced Gadd45b Promotes Epigenetic DNA Demethylation and Adult Neurogenesis

2009 720 citations K. Dengke, Mi‐Hyeon Jang et al. Science profile →
Autophagy Reduces Acute Ethanol-Induced Hepatotoxicity and Steatosis in Mice

2010 423 citations Binfeng Lu, Donna B. Stolz et al. profile →

Peers

Countries citing papers authored by Binfeng Lu

Since Specialization

Citations

This map shows the geographic impact of Binfeng Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Binfeng Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Binfeng Lu more than expected).

Fields of papers citing papers by Binfeng Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Binfeng Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Binfeng Lu. The network helps show where Binfeng Lu may publish in the future.

Co-authorship network of co-authors of Binfeng Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Binfeng Lu. A scholar is included among the top collaborators of Binfeng Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Binfeng Lu. Binfeng Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The effect of digital inclusive finance on the development of the green economy in china: A panel data analysis 2025 ·Environment Development and Sustainability ·Jiang‐Nan Wu, (unknown), (unknown), Binfeng Lu	0
2	Targeting reactive oxygen species to ameliorate T cell-mediated inflammation in dry eye syndrome: a novel therapeutic approach 2024 ·RSC Advances ·Yi Zheng, Haochen Liu, Binfeng Lu, Muchen Dong, (unknown)	1
3	Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy 2024 ·Nature Communications ·Zhangyi Luo, Yixian Huang, Neelu Batra, Yuang Chen, Haozhe Huang, Yifei Wang, Ziqian Zhang, Shichen Li, Chien‐Yu Chen, Zehua Wang, Jingjing Sun, Qiming J. Wang, Da Yang, Binfeng Lu, James F. Conway, (unknown), Ai‐Ming Yu, Song Li	30
4	An individualized causal framework for learning intercellular communication networks that define microenvironments of individual tumors 2022 ·PLoS Computational Biology ·Xueer Chen, Lujia Chen, Cornelius Kürten, (unknown), Lazar Vujanović, Ying Ding, Binfeng Lu, (unknown), Aditi Kulkarni, Tracy Tabib, Robert Lafyatis, Gregory F. Cooper, Robert L. Ferris, Xinghua Lu	3
5	Targeting Xkr8 via nanoparticle-mediated in situ co-delivery of siRNA and chemotherapy drugs for cancer immunochemotherapy 2022 ·Nature Nanotechnology ·Yuang Chen, Yixian Huang, (unknown), Zhangyi Luo, Ziqian Zhang, Haozhe Huang, Jingjing Sun, (unknown), Runzi Sun, Daniel J. Bain, James F. Conway, Binfeng Lu, Song Li	87
6	Genome-wide gain-of-function screening characterized lncRNA regulators for tumor immune response 2022 ·Science Advances ·(unknown), (unknown), Weiwei Guo, Ghanshyam S. Yadav, (unknown), Zehua Wang, (unknown), Sihan Li, Yue Wang, Yuang Chen, Dhamotharan Pattarayan, Wen Xie, Song Li, Binfeng Lu, Udai S. Kammula, Min Zhang, Da Yang	10
7	Farnesylthiosalicylic acid-derivatized PEI-based nanocomplex for improved tumor vaccination 2021 ·Molecular Therapy — Nucleic Acids ·Yuang Chen, Yixian Huang, Haozhe Huang, Zhangyi Luo, Ziqian Zhang, Runzi Sun, Zhuoya Wan, Jingjing Sun, Binfeng Lu, Song Li	11
8	Targeting metabotropic glutamate receptor 4 for cancer immunotherapy 2021 ·Science Advances ·Zhuoya Wan, Runzi Sun, Yang‐Wuyue Liu, Sihan Li, Jingjing Sun, Jiang Li, Junjie Zhu, Pearl Moharil, Bei Zhang, Pengfei Ren, Guolian Ren, Min Zhang, Xiaochao Ma, Shuang-Shuang Dai, Da Yang, Binfeng Lu, Song Li	23
9	Tumor-Derived IL33 Promotes Tissue-Resident CD8+ T Cells and Is Required for Checkpoint Blockade Tumor Immunotherapy 2020 ·Cancer Immunology Research ·Lujun Chen, Runzi Sun, (unknown), (unknown), Dachuan Zhang, Min Yang, (unknown), Yichao Chen, Song Li, Hēth Turnquist, Jingting Jiang, Binfeng Lu	41
10	Novel Effector Phenotype of Tim-3+ Regulatory T Cells Leads to Enhanced Suppressive Function in Head and Neck Cancer Patients 2018 ·Clinical Cancer Research ·Zhuqing Liu, Elizabeth L. McMichael, Gulidanna Shayan, Jing Li, Kevin Chen, Raghvendra M. Srivastava, Larry Kane, Binfeng Lu, Robert L. Ferris	91
11	PD-1 Blockade Boosts Radiofrequency Ablation–Elicited Adaptive Immune Responses against Tumor 2016 ·Clinical Cancer Research ·Liangrong Shi, Lujun Chen, Changping Wu, Yibei Zhu, Bin Xu, Xiao Zheng, (unknown), Wen Wen, (unknown), Min Yang, Quansheng Lv, Binfeng Lu, Jingting Jiang	244
12	Too Much of a Good Thing? Tim-3 and TCR Signaling in T Cell Exhaustion 2014 ·The Journal of Immunology ·Robert L. Ferris, Binfeng Lu, Larry Kane	123
13	T-Bet and Eomes Regulate the Balance between the Effector/Central Memory T Cells versus Memory Stem Like T Cells 2013 ·PLoS ONE ·Gang Li, Qianting Yang, Yibei Zhu, Hongrui Wang, Xinchun Chen, Xueguang Zhang, Binfeng Lu	57
14	IL‐33 synergizes with TCR and IL‐12 signaling to promote the effector function of CD8⁺ T cells 2011 ·European Journal of Immunology ·Qianting Yang, Gang Li, Yibei Zhu, Lin Liu, Elizabeth Chen, Hēth Turnquist, Xueguang Zhang, Olivera J. Finn, Xinchun Chen, Binfeng Lu	166
15	Two Novel Monoclonal Antibodies Against Human CD133-2: Distinct Epitopes and Agonist Activity to Enhance Growth of CD133 Expression Cells In Vitro 2010 ·Hybridoma ·Jiamin Wang, Fang Li, Guangbo Zhang, Yongjin Chen, (unknown), Xuqin Chen, Binfeng Lu, Xueguang Zhang	4
16	Neuronal Activity–Induced Gadd45b Promotes Epigenetic DNA Demethylation and Adult Neurogenesis breakdown → 2009 ·Science ·K. Dengke, Mi‐Hyeon Jang, Junjie U. Guo, Yasuji Kitabatake, (unknown), (unknown), Richard A. Flavell, Binfeng Lu, Guo‐li Ming, Hongjun Song	720
17	Characterization and Application of Two Novel Monoclonal Antibodies Against Human CXCR4: Cell Proliferation and Migration Regulation for Glioma Cell Line in vitro by CXCR4/SDF-1α Signal 2009 ·Hybridoma ·(unknown), Shiyong Zhou, (unknown), Fang Xie, Hongya Wu, Gaoqin Liu, Qin Wang, Yongjin Chen, (unknown), Binfeng Lu, Xueguang Zhang	10
18	Autophagy Is Induced in CD4+ T Cells and Important for the Growth Factor-Withdrawal Cell Death 2006 ·The Journal of Immunology ·Changyou Li, (unknown), Yani Zhao, Jianping Zhao, Donna B. Stolz, Simon C. Watkins, Xin Jin, Binfeng Lu	236
19	A2 GADD45β is novel mediator of MMP-13 gene expression during chondrocyte hypertrophy 2005 ·Osteoarthritis and Cartilage ·B.C. Søndergaard, Kim Henriksen, (unknown), Søren Østergaard, Per Qvist, Yu Z. Bagger, Claus Christiansen, (unknown), M.A. Karsdal, Kosei Ijiri, Luiz F. Zerbini, Haibing Peng, Nicole C. Walsh, Xiaogang Huang, Hasan H. Otu, Binfeng Lu, Towia A. Libermann, Mary B. Goldring	1
20	The Hematopoiesis-Specific GTP-Binding Protein RhoH Is GTPase Deficient and Modulates Activities of Other Rho GTPases by an Inhibitory Function 2002 ·Molecular and Cellular Biology ·Xiaoyu Li, Xia Bu, Binfeng Lu, Hava Avraham, Richard A. Flavell, Bing Lim	116

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact